LivingGLP1
Glucagon and GLP-1 receptor co-agonist

Pemvidutide 1.2 mg subcutaneous once weekly

PEMV_SC_1p2MG_QW

Agent
pemvidutide
Route
SC
Dose
1.2 mg
Frequency
QW
Dosing
fixed
Mechanism
Dual agonist (survodutide; mazdutide; cotadutide; efinopegdutide; pemvidutide)
Trials
0
Participants in these arms
0

Trials